These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19153557)
1. Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis. Ceyhan GO; Deucker S; Demir IE; Erkan M; Schmelz M; Bergmann F; Müller MW; Giese T; Büchler MW; Giese NA; Friess H Lab Invest; 2009 Mar; 89(3):347-61. PubMed ID: 19153557 [TBL] [Abstract][Full Text] [Related]
2. The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy? D'Haese JG; Demir IE; Kehl T; Winckler J; Giese NA; Bergmann F; Giese T; Büchler MW; Friess H; Hartel M; Ceyhan GO BMC Gastroenterol; 2013 Jan; 13():14. PubMed ID: 23324439 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuropathy results in "neural remodeling" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer. Ceyhan GO; Demir IE; Rauch U; Bergmann F; Müller MW; Büchler MW; Friess H; Schäfer KH Am J Gastroenterol; 2009 Oct; 104(10):2555-65. PubMed ID: 19568227 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist. Uchida M; Ito T; Nakamura T; Hijioka M; Igarashi H; Oono T; Kato M; Nakamura K; Suzuki K; Takayanagi R; Jensen RT Pancreas; 2014 Jul; 43(5):708-19. PubMed ID: 24681877 [TBL] [Abstract][Full Text] [Related]
5. The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Ceyhan GO; Bergmann F; Kadihasanoglu M; Erkan M; Park W; Hinz U; Giese T; Müller MW; Büchler MW; Giese NA; Friess H Gut; 2007 Apr; 56(4):534-44. PubMed ID: 17047099 [TBL] [Abstract][Full Text] [Related]
6. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. Demir IE; Schorn S; Schremmer-Danninger E; Wang K; Kehl T; Giese NA; Algül H; Friess H; Ceyhan GO PLoS One; 2013; 8(3):e60529. PubMed ID: 23555989 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases. Ceyhan GO; Bergmann F; Kadihasanoglu M; Altintas B; Demir IE; Hinz U; Müller MW; Giese T; Büchler MW; Giese NA; Friess H Gastroenterology; 2009 Jan; 136(1):177-186.e1. PubMed ID: 18992743 [TBL] [Abstract][Full Text] [Related]
8. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine. Oh IS; Suh DW; Ha KY Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055 [TBL] [Abstract][Full Text] [Related]
9. Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration. Zhang M; Xu G; Liu W; Ni Y; Zhou W PLoS One; 2012; 7(4):e35446. PubMed ID: 22536384 [TBL] [Abstract][Full Text] [Related]
10. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082 [TBL] [Abstract][Full Text] [Related]
11. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis. Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294 [TBL] [Abstract][Full Text] [Related]
12. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? Cormican S; Griffin MD Front Immunol; 2021; 12():664202. PubMed ID: 34163473 [TBL] [Abstract][Full Text] [Related]
13. Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 Conroy MJ; Maher SG; Melo AM; Doyle SL; Foley E; Reynolds JV; Long A; Lysaght J Front Immunol; 2018; 9():1867. PubMed ID: 30150990 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update. D'Haese JG; Friess H; Ceyhan GO Expert Opin Ther Targets; 2012 Jun; 16(6):613-8. PubMed ID: 22530606 [TBL] [Abstract][Full Text] [Related]
15. Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Wang H; Cai J; Du S; Guo Z; Xin B; Wang J; Wei W; Shen X Cell Biochem Funct; 2017 Aug; 35(6):315-326. PubMed ID: 28845524 [TBL] [Abstract][Full Text] [Related]
16. RB1CC1-enhanced autophagy facilitates PSCs activation and pancreatic fibrogenesis in chronic pancreatitis. Li L; Wang G; Hu JS; Zhang GQ; Chen HZ; Yuan Y; Li YL; Lv XJ; Tian FY; Pan SH; Bai XW; Sun B Cell Death Dis; 2018 Sep; 9(10):952. PubMed ID: 30237496 [TBL] [Abstract][Full Text] [Related]
17. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway. Huang L; Ma B; Ma J; Wang F Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258 [TBL] [Abstract][Full Text] [Related]
18. Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Shah R; Hinkle CC; Ferguson JF; Mehta NN; Li M; Qu L; Lu Y; Putt ME; Ahima RS; Reilly MP Diabetes; 2011 May; 60(5):1512-8. PubMed ID: 21525510 [TBL] [Abstract][Full Text] [Related]
19. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931 [TBL] [Abstract][Full Text] [Related]
20. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]